Last update 06 Apr 2025

rSIFN-co

Overview

Basic Info

Drug Type
Interferons
Synonyms
Crystalline recombinant interferon, Recombinant super compound interferon, Recombinant super interferon compound
+ [1]
Target
Action
agonists
Mechanism
IFNLR1 agonists(interferon lambda receptor 1 agonists)
Active Indication
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Hepatitis B, ChronicPhase 3
China
17 Sep 2011
COVID-19Phase 2
Philippines
01 Jul 2022
Colorectal CancerPhase 1
United States
01 Jan 2016
Kidney NeoplasmsPhase 1
United States
01 Jan 2016
Lung CancerPhase 1
United States
01 Jan 2016
Prostatic CancerPhase 1
United States
01 Jan 2016
Advanced Malignant Solid NeoplasmPhase 1
Singapore
01 Jul 2013
Colonic CancerPhase 1
Singapore
01 Jul 2013
Hepatocellular CarcinomaPhase 1
Singapore
01 Jul 2013
MelanomaPhase 1
Singapore
01 Jul 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1
39
hjzonkuhoz(kqusxreoag) = enxjojuipj ftmvcegwam (vtxxlcwvju )
-
28 Sep 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free